News Room
Pro Research: Wall Street takes on Amgen’s diverse prospects
© Reuters. Explore Wall Street's expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon.…
Calliditas Therapeutics Shares Rise 33% After FDA Approves Tarpeyo
By Stephen Nakrosis Shares of Calliditas Therapeutics were topping previous 52-week highs in Wednesday's late-trading session after the company said…
Failed Warburg Pincus talks reveal scale of BlackRock’s private equity ambitions
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.BlackRock’s push…
How to build a business empire: ‘Great entrepreneurs make sacrifices,’ says Skims Co-Founder
Watch full video on YouTube
YS Biopharma Says Fake Press Release Called for Extraordinary General Meeting
By Ben Glickman YS Biopharma said a fake press release distributed under the company's name called for an extraordinary general…
Why Cars Lose Their Value So Fast
Watch full video on YouTube
Rudy Giuliani files for bankruptcy after $148mn defamation judgment
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Rudy Giuliani,…
5 Biotech Acquisition Targets To Accumulate In 2024
Introduction The biotech market took a back seat from 2021 to 2023 as valuations remained high and M&A interest faded.…